$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 2 3 4 5 6 7 ... 53 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Sell | S | 88.97 | 1,019 | 90,660 | 52,985 | 54 K to 53 K (-1.89 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Payment of Exercise | F | 89.66 | 1,004 | 90,019 | 54,004 | 55 K to 54 K (-1.83 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Payment of Exercise | F | 89.66 | 1,020 | 91,453 | 55,008 | 56 K to 55 K (-1.82 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | DALE MICHAEL D | Senior Vice Preside ... | Sell | S | 88.97 | 396 | 35,232 | 23,947 | 24.3 K to 23.9 K (-1.63 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | DALE MICHAEL D | Senior Vice Preside ... | Payment of Exercise | F | 89.66 | 951 | 85,267 | 24,343 | 25.3 K to 24.3 K (-3.76 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Payment of Exercise | F | 89.66 | 710 | 63,659 | 12,958 | 13.7 K to 13 K (-5.19 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 89.66 | 471 | 42,230 | 65,567 | 66 K to 65.6 K (-0.71 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Payment of Exercise | F | 89.66 | 771 | 69,128 | 14,705 | 15.5 K to 14.7 K (-4.98 %) |
Feb 19 2020 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Payment of Exercise | F | 89.66 | 814 | 72,983 | 15,476 | 16.3 K to 15.5 K (-5.00 %) |
Feb 11 2020 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Sell | S | 88.61 | 1,120 | 99,245 | 40,140 | 41.3 K to 40.1 K (-2.71 %) |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 59.94 | 82,321 | 4,934,321 | 164,642 | |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 44.40 | 91,121 | 4,045,772 | 45,561 | |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 38.40 | 213,470 | 8,197,248 | 0 | |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 48.90 | 81,709 | 3,995,570 | 0 | |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 47.00 | 41,229 | 1,937,763 | 0 | |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Sell | S | 89.73 | 509,850 | 45,747,209 | 114,381 | 624.2 K to 114.4 K (-81.68 %) |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 59.94 | 82,321 | 4,934,321 | 624,231 | 541.9 K to 624.2 K (+15.19 %) |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 44.40 | 91,121 | 4,045,772 | 541,910 | 450.8 K to 541.9 K (+20.21 %) |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 38.40 | 213,470 | 8,197,248 | 450,789 | 237.3 K to 450.8 K (+89.95 %) |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 48.90 | 81,709 | 3,995,570 | 237,319 | 155.6 K to 237.3 K (+52.51 %) |
Jan 30 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 47.00 | 41,229 | 1,937,763 | 155,610 | 114.4 K to 155.6 K (+36.05 %) |
Jan 29 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | M | 38.40 | 37,500 | 1,440,000 | 37,500 | |
Jan 29 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 89.58 | 37,500 | 3,359,411 | 50,534 | 88 K to 50.5 K (-42.60 %) |
Jan 29 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Buy | M | 38.40 | 37,500 | 1,440,000 | 88,032 | 50.5 K to 88 K (+74.21 %) |
Jan 03 2020 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 362 | 0 | 4,651 | |
Jan 03 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 7,766 | |
Jan 03 2020 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 86.80 | 7,182 | 623,398 | 66,038 | 73.2 K to 66 K (-9.81 %) |
Dec 30 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 507 | 0 | 0 | 507 to 0 (-100.00 %) |
Dec 30 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 507 | 0 | 507 | 0 to 507 |
Dec 30 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 298 | 0 | 3,160,471 | 3.2 M to 3.2 M (-0.01 %) |
Dec 30 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 12,382 | 0 | 3,160,769 | 3.2 M to 3.2 M (-0.39 %) |
Dec 30 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 1,014 | 0 | 3,173,151 | 3.2 M to 3.2 M (-0.03 %) |
Oct 25 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Option Exercise | M | 38.40 | 16,000 | 614,400 | 2,333 | |
Oct 25 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Sell | S | 80.60 | 5,000 | 403,000 | 47,562 | 52.6 K to 47.6 K (-9.51 %) |
Oct 25 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Sell | S | 80.52 | 16,000 | 1,288,315 | 52,562 | 68.6 K to 52.6 K (-23.34 %) |
Oct 25 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Buy | M | 38.40 | 16,000 | 614,400 | 68,562 | 52.6 K to 68.6 K (+30.44 %) |
Oct 02 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 376 | 0 | 4,273 | |
Oct 02 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 94 | 0 | 7,647 | |
Sep 04 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | M | 47.00 | 47,226 | 2,219,622 | 0 | |
Sep 04 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 85.14 | 47,226 | 4,020,685 | 50,532 | 97.8 K to 50.5 K (-48.31 %) |
Sep 04 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Buy | M | 47.00 | 47,226 | 2,219,622 | 97,755 | 50.5 K to 97.8 K (+93.46 %) |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Option Exercise | M | 50.72 | 23,008 | 1,166,966 | 46,016 | |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Gift | G | 0.00 | 8,000 | 0 | 73,220 | 81.2 K to 73.2 K (-9.85 %) |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Sell | S | 86.39 | 23,008 | 1,987,705 | 81,220 | 104.2 K to 81.2 K (-22.07 %) |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Buy | M | 50.72 | 23,008 | 1,166,966 | 104,228 | 81.2 K to 104.2 K (+28.33 %) |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 34.94 | 40,000 | 1,397,600 | 23,700 | |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Payment of Exercise | F | 85.56 | 26,818 | 2,294,548 | 152,173 | 179 K to 152.2 K (-14.98 %) |
Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 34.94 | 40,000 | 1,397,600 | 178,991 | 139 K to 179 K (+28.78 %) |
Aug 09 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 39.12 | 32,363 | 1,266,041 | 0 | |
Aug 09 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | M | 34.94 | 11,400 | 398,316 | 0 | |
Aug 09 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Sell | S | 85.77 | 43,763 | 3,753,706 | 114,381 | 158.1 K to 114.4 K (-27.67 %) |
Aug 09 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 39.12 | 32,363 | 1,266,041 | 158,144 | 125.8 K to 158.1 K (+25.73 %) |
Aug 09 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Buy | M | 34.94 | 11,400 | 398,316 | 125,781 | 114.4 K to 125.8 K (+9.97 %) |
Aug 05 2019 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Option Exercise | A | 86.86 | 60,912 | 5,290,816 | 60,912 | |
Aug 05 2019 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Grant | A | 0.00 | 8,426 | 0 | 56,028 | 47.6 K to 56 K (+17.70 %) |
Aug 02 2019 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Sell | S | 87.65 | 2,500 | 219,121 | 26,266 | 28.8 K to 26.3 K (-8.69 %) |
Jul 31 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Gift | G | 0.00 | 2,860 | 0 | 56,947 | 59.8 K to 56.9 K (-4.78 %) |
Jul 26 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Option Exercise | M | 38.40 | 65,000 | 2,496,000 | 18,333 | |
Jul 26 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Sell | S | 88.01 | 65,000 | 5,720,325 | 52,562 | 117.6 K to 52.6 K (-55.29 %) |
Jul 26 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Buy | M | 38.40 | 65,000 | 2,496,000 | 117,562 | 52.6 K to 117.6 K (+123.66 %) |
Jul 26 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Option Exercise | M | 38.40 | 65,000 | 2,496,000 | 18,333 | |
Jul 26 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Sell | S | 88.01 | 65,000 | 5,720,325 | 52,562 | 117.6 K to 52.6 K (-55.29 %) |
Jul 26 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Buy | M | 38.40 | 65,000 | 2,496,000 | 117,562 | 52.6 K to 117.6 K (+123.66 %) |
Jul 25 2019 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Payment of Exercise | F | 88.74 | 1,650 | 146,421 | 39,461 | 41.1 K to 39.5 K (-4.01 %) |
Jul 23 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 87.49 | 2,437 | 213,213 | 81,220 | 83.7 K to 81.2 K (-2.91 %) |
Jul 23 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 87.49 | 1,060 | 92,739 | 95,088 | 96.1 K to 95.1 K (-1.10 %) |
Jul 23 2019 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Payment of Exercise | F | 87.49 | 524 | 45,845 | 13,668 | 14.2 K to 13.7 K (-3.69 %) |
Jul 23 2019 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Grant | A | 0.00 | 1,497 | 0 | 14,192 | 12.7 K to 14.2 K (+11.79 %) |
Jul 01 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 374 | 0 | 3,881 | |
Jul 01 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 93 | 0 | 7,524 | |
Jun 27 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 38.40 | 71,000 | 2,726,400 | 71,313 | |
Jun 27 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 84.00 | 71,000 | 5,964,007 | 96,148 | 167.1 K to 96.1 K (-42.48 %) |
Jun 27 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 38.40 | 71,000 | 2,726,400 | 167,148 | 96.1 K to 167.1 K (+73.84 %) |
Jun 24 2019 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Sell | S | 85.13 | 1,188 | 101,134 | 41,260 | 42.4 K to 41.3 K (-2.80 %) |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 26.19 | 46,900 | 1,228,213 | 0 | |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 85.00 | 46,900 | 3,986,500 | 308,535 | 355.4 K to 308.5 K (-13.20 %) |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 26.19 | 46,900 | 1,228,213 | 355,435 | 308.5 K to 355.4 K (+15.20 %) |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | M | 34.94 | 165,000 | 5,765,100 | 0 | |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 85.00 | 165,000 | 14,025,000 | 146,010 | 311 K to 146 K (-53.05 %) |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Buy | M | 34.94 | 165,000 | 5,765,100 | 311,010 | 146 K to 311 K (+113.01 %) |
Jun 14 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | M | 48.90 | 73,424 | 3,590,434 | 41,268 | |
Jun 14 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Sell | S | 81.42 | 73,424 | 5,978,197 | 45,938 | 119.4 K to 45.9 K (-61.51 %) |
Jun 14 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Buy | M | 48.90 | 73,424 | 3,590,434 | 119,362 | 45.9 K to 119.4 K (+159.83 %) |
Jun 13 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 82.00 | 3,331 | 273,142 | 96,148 | 99.5 K to 96.1 K (-3.35 %) |
Jun 13 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 82.00 | 7,269 | 596,058 | 99,479 | 106.7 K to 99.5 K (-6.81 %) |
Jun 12 2019 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Option Exercise | A | 80.98 | 91,367 | 7,398,900 | 91,367 | |
Jun 12 2019 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Grant | A | 0.00 | 39,515 | 0 | 56,946 | 17.4 K to 56.9 K (+226.69 %) |
Jun 12 2019 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Grant | A | 0.00 | 17,431 | 0 | 17,431 | 0 to 17.4 K |
Jun 10 2019 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Gift | G | 0.00 | 18,833 | 0 | 114,325 | 95.5 K to 114.3 K (+19.72 %) |
Jun 10 2019 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Gift | G | 0.00 | 18,833 | 0 | 83,057 | 101.9 K to 83.1 K (-18.48 %) |
Jun 05 2019 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Option Exercise | A | 76.12 | 62,725 | 4,774,627 | 62,725 | |
Jun 05 2019 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Grant | A | 0.00 | 11,967 | 0 | 42,448 | 30.5 K to 42.4 K (+39.26 %) |
Jun 05 2019 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | A | 76.12 | 62,725 | 4,774,627 | 62,725 | |
Jun 05 2019 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Grant | A | 0.00 | 11,967 | 0 | 60,584 | 48.6 K to 60.6 K (+24.61 %) |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 38.40 | 56,735 | 2,178,624 | 300,000 | |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 47.00 | 53,163 | 2,498,661 | 120,000 | |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 39.12 | 175,164 | 6,852,416 | 0 | |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 34.94 | 165,000 | 5,765,100 | 0 | |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 75.52 | 450,062 | 33,988,727 | 130,745 | 580.8 K to 130.7 K (-77.49 %) |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 38.40 | 56,735 | 2,178,624 | 580,807 | 524.1 K to 580.8 K (+10.83 %) |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 47.00 | 53,163 | 2,498,661 | 524,072 | 470.9 K to 524.1 K (+11.29 %) |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 39.12 | 175,164 | 6,852,416 | 470,909 | 295.7 K to 470.9 K (+59.23 %) |
May 24 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 34.94 | 165,000 | 5,765,100 | 295,745 | 130.7 K to 295.7 K (+126.20 %) |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | M | 59.94 | 50,994 | 3,056,580 | 101,987 | |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | M | 44.40 | 34,086 | 1,513,418 | 17,043 | |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | M | 38.40 | 109,657 | 4,210,829 | 0 | |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | M | 48.04 | 114,692 | 5,509,804 | 0 | |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 78.51 | 309,429 | 24,294,199 | 74,535 | 384 K to 74.5 K (-80.59 %) |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Buy | M | 59.94 | 50,994 | 3,056,580 | 383,964 | 333 K to 384 K (+15.31 %) |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Buy | M | 44.40 | 34,086 | 1,513,418 | 332,970 | 298.9 K to 333 K (+11.40 %) |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Buy | M | 38.40 | 109,657 | 4,210,829 | 298,884 | 189.2 K to 298.9 K (+57.95 %) |
May 06 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Buy | M | 48.04 | 114,692 | 5,509,804 | 189,227 | 74.5 K to 189.2 K (+153.88 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Option Exercise | A | 78.06 | 11,606 | 905,964 | 11,606 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Grant | A | 0.00 | 2,241 | 0 | 28,153 | 25.9 K to 28.2 K (+8.65 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Grant | A | 0.00 | 2,241 | 0 | 8,641 | 6.4 K to 8.6 K (+35.02 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Grant | A | 0.00 | 2,241 | 0 | 8,641 | 6.4 K to 8.6 K (+35.02 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 78.06 | 11,990 | 935,939 | 11,990 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 78.06 | 11,990 | 935,939 | 11,990 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Grant | A | 0.00 | 2,241 | 0 | 56,323 | 54.1 K to 56.3 K (+4.14 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Grant | A | 0.00 | 2,241 | 0 | 56,323 | 54.1 K to 56.3 K (+4.14 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Option Exercise | A | 78.06 | 10,146 | 791,997 | 10,146 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Option Exercise | A | 78.06 | 10,146 | 791,997 | 10,146 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Grant | A | 0.00 | 2,241 | 0 | 40,053 | 37.8 K to 40.1 K (+5.93 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Grant | A | 0.00 | 2,241 | 0 | 40,053 | 37.8 K to 40.1 K (+5.93 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Grant | A | 0.00 | 2,241 | 0 | 28,766 | 26.5 K to 28.8 K (+8.45 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Grant | A | 0.00 | 2,241 | 0 | 28,766 | 26.5 K to 28.8 K (+8.45 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Option Exercise | A | 78.06 | 11,683 | 911,975 | 11,683 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,241 | 0 | 44,913 | 42.7 K to 44.9 K (+5.25 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 2,241 | 0 | 30,406 | 28.2 K to 30.4 K (+7.96 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 2,241 | 0 | 7,018,425 | 7 M to 7 M (+0.03 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Kumbier Michelle | Director | Grant | A | 0.00 | 2,241 | 0 | 3,258 | 1 K to 3.3 K (+220.35 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 2,241 | 0 | 41,053 | 38.8 K to 41.1 K (+5.77 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Option Exercise | A | 78.06 | 10,146 | 791,997 | 10,146 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Grant | A | 0.00 | 2,241 | 0 | 23,666 | 21.4 K to 23.7 K (+10.46 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Option Exercise | A | 78.06 | 10,837 | 845,936 | 10,837 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Grant | A | 0.00 | 2,241 | 0 | 26,333 | 24.1 K to 26.3 K (+9.30 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 38.40 | 80,860 | 3,105,024 | 0 | |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 59.94 | 36,716 | 2,200,757 | 73,430 | |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,016 | 2,043,110 | 46,016 | |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 78.11 | 57,962 | 4,527,412 | 57,604 | 115.6 K to 57.6 K (-50.15 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 38.40 | 80,860 | 3,105,024 | 115,566 | 34.7 K to 115.6 K (+232.99 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 70.02 | 12,332 | 863,487 | 34,706 | 47 K to 34.7 K (-26.22 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 70.00 | 70,400 | 4,928,000 | 47,038 | 117.4 K to 47 K (-59.95 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 59.94 | 36,716 | 2,200,757 | 117,438 | 80.7 K to 117.4 K (+45.48 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,016 | 2,043,110 | 80,722 | 34.7 K to 80.7 K (+132.59 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 47.00 | 56,000 | 2,632,000 | 113,227 | |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 76.00 | 56,000 | 4,256,000 | 169,935 | 225.9 K to 169.9 K (-24.79 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 47.00 | 56,000 | 2,632,000 | 225,935 | 169.9 K to 225.9 K (+32.95 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 73.12 | 918 | 67,124 | 2,227 | 3.1 K to 2.2 K (-29.19 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Buy | P | 73.40 | 2,000 | 146,798 | 52,562 | 50.6 K to 52.6 K (+3.96 %) |